Ocular Therapeutix
Ocular slapped with CRL despite last-ditch efforts
July 12, 2017Dextenza, Ocular Therapeutix, biotech, drugs, pharma, pharmaceutical
Ocular Therapeutix received a second CRL for its drug, Dextenza, despite submitting a last-minute application for an extension to its …
Regeneron and Ocular Therapeutix to collaborate in potential $315 million deal
October 14, 2016Medical Communications Bayer, Eyelea, Ocular Therapeutix, Regeneron Pharmaceuticals, wet AMD
Regeneron Pharmaceuticals and Ocular Therapeutix have entered into a deal that will see them collaborate to develop a sustained release …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
